Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan H Fox

Showing results (31-40 of 178) with videos related to

Pageof 18
Sort By:
Continuum (Minneapolis, Minn.)|August 7, 2016
Treating the Motor Symptoms of Parkinson DiseaseJohn C Morgan, Susan H Fox
Handbook of Clinical Neurology|September 24, 2008
Motor and non-motor fluctuationsSusan H Fox, Anthony E Lang
The European Journal of Neuroscience|October 1, 2018
Viewpoint: Developing drugs for levodopa-induced dyskinesia in PD: Lessons learnt, what does the future hold?Susan H Fox, Jonathan M Brotchie
Current Opinion in Neurology|May 11, 2018
Update in therapeutic strategies for Parkinson's diseaseJaime Kulisevsky, Lais Oliveira, Susan H Fox
Progress in Brain Research|September 6, 2008
Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndromeThomas D L Steeves, Susan H Fox
Parkinson'S Disease|March 27, 2015
Monoamine reuptake inhibitors in Parkinson's diseasePhilippe Huot, Susan H Fox, Jonathan M Brotchie
Progress in Brain Research|September 6, 2008
Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapySusan H Fox, Rosalind Chuang, Jonathan M Brotchie
Expert Opinion on Investigational Drugs|February 16, 2013
5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disordersTiago A Mestre, Mateusz Zurowski, Susan H Fox
Expert Opinion on Emerging Drugs|June 11, 2025
Motor fluctuations in Parkinson disease - a mini-review of emerging drugsPriti Gros, Laura Armengou Garcia, Susan H Fox
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical TrialsPhilippe Huot, Susan H Fox, Jonathan M Brotchie
Pageof 18

Showing results (31-40 of 178) with videos related to

Sort By:
Pageof 18
Continuum (Minneapolis, Minn.)|August 7, 2016
Treating the Motor Symptoms of Parkinson DiseaseJohn C Morgan, Susan H Fox
Handbook of Clinical Neurology|September 24, 2008
Motor and non-motor fluctuationsSusan H Fox, Anthony E Lang
The European Journal of Neuroscience|October 1, 2018
Viewpoint: Developing drugs for levodopa-induced dyskinesia in PD: Lessons learnt, what does the future hold?Susan H Fox, Jonathan M Brotchie
Current Opinion in Neurology|May 11, 2018
Update in therapeutic strategies for Parkinson's diseaseJaime Kulisevsky, Lais Oliveira, Susan H Fox
Progress in Brain Research|September 6, 2008
Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndromeThomas D L Steeves, Susan H Fox
Parkinson'S Disease|March 27, 2015
Monoamine reuptake inhibitors in Parkinson's diseasePhilippe Huot, Susan H Fox, Jonathan M Brotchie
Progress in Brain Research|September 6, 2008
Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapySusan H Fox, Rosalind Chuang, Jonathan M Brotchie
Expert Opinion on Investigational Drugs|February 16, 2013
5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disordersTiago A Mestre, Mateusz Zurowski, Susan H Fox
Expert Opinion on Emerging Drugs|June 11, 2025
Motor fluctuations in Parkinson disease - a mini-review of emerging drugsPriti Gros, Laura Armengou Garcia, Susan H Fox
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of Nonhuman Primate Studies and Clinical TrialsPhilippe Huot, Susan H Fox, Jonathan M Brotchie
Pageof 18